NR565 Week 8 Final Exam
Latest 2026 | NR 565 Advanced Pharmacology Fundamentals
Complete Exam | All 100 Questions and Correct Answers
Proctored via Examplify | Graded A+ | 100% Pass Guaranteed
✔ 100 Questions ✔ Verified Answers ✔ Rationales Included ✔ A+ Grade
Course: NR565 Advanced Pharmacology Fundamentals Term: 2026 Exam Type: Final Exam (Proctored) Total
Questions: 100 Format: Multiple Choice with Rationales
This study guide is intended for educational preparation purposes. All questions are written to reflect the scope and level of NR565
Advanced Pharmacology Fundamentals. Rationales are provided to reinforce understanding of key pharmacological principles.
, A patient takes a medication with a half-life of 8 hours. Approximately how long will
1 it take to reach steady-state plasma concentrations?
A. 8 hours
B. 16 hours
C. 40 hours
D. 80 hours
✔ CORRECT ANSWER
C. 40 hours
Rationale: Steady state is reached after approximately 4–5 half-lives. With an 8-hour half-life: 5 × 8 = 40
hours.
Which pharmacokinetic parameter describes the relationship between drug
2 concentration and the body's ability to eliminate that drug?
A. Volume of distribution
B. Clearance
C. Bioavailability
D. Protein binding
✔ CORRECT ANSWER
B. Clearance
Rationale: Clearance (CL) defines the volume of plasma cleared of drug per unit time and is the primary
determinant of steady-state concentration.
,3 A highly lipophilic drug with extensive tissue binding would be expected to have:
A. A small volume of distribution
B. A large volume of distribution
C. High renal clearance
D. Low protein binding
✔ CORRECT ANSWER
B. A large volume of distribution
Rationale: Lipophilic drugs distribute extensively into tissues, resulting in a large volume of distribution (Vd
> 1 L/kg).
First-pass metabolism significantly reduces the bioavailability of which route of
4 administration?
A. Intravenous
B. Sublingual
C. Oral
D. Transdermal
✔ CORRECT ANSWER
C. Oral
Rationale: Orally administered drugs pass through the portal circulation and hepatic metabolism before
reaching systemic circulation, reducing bioavailability.
, Which cytochrome P450 enzyme is responsible for metabolizing the largest number
5 of clinically used drugs?
A. CYP1A2
B. CYP2C9
C. CYP3A4
D. CYP2D6
✔ CORRECT ANSWER
C. CYP3A4
Rationale: CYP3A4 metabolizes approximately 50% of all clinically used drugs and is found in both the
liver and intestinal wall.
Rifampin induces CYP3A4. A patient on warfarin starts rifampin. What is the
6 expected pharmacokinetic effect?
A. Increased warfarin levels, bleeding risk
B. Decreased warfarin levels, clotting risk
C. No change in warfarin levels
D. Increased warfarin half-life
✔ CORRECT ANSWER
B. Decreased warfarin levels, clotting risk
Rationale: CYP3A4 induction by rifampin accelerates warfarin metabolism, lowering plasma levels and
increasing thrombotic risk.
Latest 2026 | NR 565 Advanced Pharmacology Fundamentals
Complete Exam | All 100 Questions and Correct Answers
Proctored via Examplify | Graded A+ | 100% Pass Guaranteed
✔ 100 Questions ✔ Verified Answers ✔ Rationales Included ✔ A+ Grade
Course: NR565 Advanced Pharmacology Fundamentals Term: 2026 Exam Type: Final Exam (Proctored) Total
Questions: 100 Format: Multiple Choice with Rationales
This study guide is intended for educational preparation purposes. All questions are written to reflect the scope and level of NR565
Advanced Pharmacology Fundamentals. Rationales are provided to reinforce understanding of key pharmacological principles.
, A patient takes a medication with a half-life of 8 hours. Approximately how long will
1 it take to reach steady-state plasma concentrations?
A. 8 hours
B. 16 hours
C. 40 hours
D. 80 hours
✔ CORRECT ANSWER
C. 40 hours
Rationale: Steady state is reached after approximately 4–5 half-lives. With an 8-hour half-life: 5 × 8 = 40
hours.
Which pharmacokinetic parameter describes the relationship between drug
2 concentration and the body's ability to eliminate that drug?
A. Volume of distribution
B. Clearance
C. Bioavailability
D. Protein binding
✔ CORRECT ANSWER
B. Clearance
Rationale: Clearance (CL) defines the volume of plasma cleared of drug per unit time and is the primary
determinant of steady-state concentration.
,3 A highly lipophilic drug with extensive tissue binding would be expected to have:
A. A small volume of distribution
B. A large volume of distribution
C. High renal clearance
D. Low protein binding
✔ CORRECT ANSWER
B. A large volume of distribution
Rationale: Lipophilic drugs distribute extensively into tissues, resulting in a large volume of distribution (Vd
> 1 L/kg).
First-pass metabolism significantly reduces the bioavailability of which route of
4 administration?
A. Intravenous
B. Sublingual
C. Oral
D. Transdermal
✔ CORRECT ANSWER
C. Oral
Rationale: Orally administered drugs pass through the portal circulation and hepatic metabolism before
reaching systemic circulation, reducing bioavailability.
, Which cytochrome P450 enzyme is responsible for metabolizing the largest number
5 of clinically used drugs?
A. CYP1A2
B. CYP2C9
C. CYP3A4
D. CYP2D6
✔ CORRECT ANSWER
C. CYP3A4
Rationale: CYP3A4 metabolizes approximately 50% of all clinically used drugs and is found in both the
liver and intestinal wall.
Rifampin induces CYP3A4. A patient on warfarin starts rifampin. What is the
6 expected pharmacokinetic effect?
A. Increased warfarin levels, bleeding risk
B. Decreased warfarin levels, clotting risk
C. No change in warfarin levels
D. Increased warfarin half-life
✔ CORRECT ANSWER
B. Decreased warfarin levels, clotting risk
Rationale: CYP3A4 induction by rifampin accelerates warfarin metabolism, lowering plasma levels and
increasing thrombotic risk.
